Atlas Trials

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Clinical trial NCT00190996 · COMPLETED

Trial details

NCT number
NCT00190996
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Urinary Incontinence, Stress
Start date
2003-01-01
Enrollment
2765

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.